Skip to main content

Table 2 Data of all secondary outcome measures

From: Feasibility and outcome of metacognitive therapy for major depressive disorder: a pilot study

 

Pre

Post

Follow-up

Friedman-Test

Dunn-Bonferroni-Tests and effect sizes

T0-T1

Dunn-Bonferroni-Tests and effect sizes

T0-T2

MCQ-30

61.4 ± 12.9

49.5 ± 10.8

45.5 ± 10.4

χ2(2) = 24.4, p < 0.01

z = 2.7, p < 0.05; r = 0.6

z = 4.9, p < 0.01, r = 1.1

PBRS

20.8 ± 5.5

14.4 ± 6.7

13.7 ± 7.1

χ2(2) = 14.4, p < 0.01

z = 2.7, p < 0.05; r = 0.6

z = 3.4, p < 0.01, r = 0.8

NBRS

26.9 ± 6.6

21 ± 5.6

19.3 ± 6

χ2(2) = 12.2, p < 0.01

z = 2.2, p = 0.09, r = 0.5

z = 3.4, p < 0.01, r = 0.8

BDI-2

29 ± 8.6

13 ± 8.4

8.4 ± 9.6

χ2(2) = 33.6, p < 0.01

z = 3.8, p < 0.01; r = 0.8

z = 5.7, p < 0.01; r = 1.3

  1. MCQ-30 Metacognitions Questionnaire-30, PBRS Positive beliefs about rumination scale, NBRS negative beliefs about rumination scale, BDI-2 Beck Depression Inventory-2